TET2 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data strongly suggest that the up-regulation of miR-29a-3p observed in CML LSCs is responsible for TET2 downregulation, which in turn is able to confer IM-resistance to CML LSCs.